These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2523652)

  • 1. Detection and monitoring of asymptomatic atherosclerosis in clinical trials.
    Bond MG; Wilmoth SK; Enevold GL; Strickland HL
    Am J Med; 1989 Apr; 86(4A):33-6. PubMed ID: 2523652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
    Furberg CD; Byington RP; Borhani NA
    Am J Med; 1989 Apr; 86(4A):37-9. PubMed ID: 2523653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventional clinical trials using noninvasive ultrasound end points: the Multicenter Isradipine/Diuretic Atherosclerosis Study. The MIDAS Research Group.
    Bond MG; Strickland HL; Wilmoth SK; Safrit A; Phillips R; Szostak L
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S30-3. PubMed ID: 1695299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.
    Applegate WB; Byington RP
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group.
    Borhani NO; Brugger SB; Byington RP
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S23-9. PubMed ID: 1695298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
    Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Grimm RH; Flack JM; Byington R; Bond G; Brugger S
    Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
    Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.
    Borhani NO; Mercuri M; Borhani PA; Buckalew VM; Canossa-Terris M; Carr AA; Kappagoda T; Rocco MV; Schnaper HW; Sowers JR; Bond MG
    JAMA; 1996 Sep; 276(10):785-91. PubMed ID: 8769587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study.
    Hansson L; Zanchetti A
    Blood Press; 1995 May; 4(3):133-6. PubMed ID: 7670645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
    Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isradipine, a new calcium antagonist on the lipid profile in patients with hypertension.
    Samuel P
    Cor Vasa; 1990; 32(2 Suppl 1):35-41. PubMed ID: 2143459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
    Borhani NO
    Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials.
    Zanchetti A
    Clin Exp Hypertens; 1996; 18(3-4):489-99. PubMed ID: 8743037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of isradipine, a new calcium antagonist, versus hydrochlorothiazide on serum lipids and apolipoproteins in patients with systemic hypertension.
    Samuel P; Kirkendall W; Schaefer EJ; Chin B; Schoenfeld BH; Gonasun LM; Lieberman S
    Am J Cardiol; 1988 Nov; 62(16):1068-71. PubMed ID: 2973219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive quantitative evaluation of early atherosclerosis and the effect of monatepil, a new antihypertensive agent. An interim report.
    Tsushima M; Koh H; Suzuki M; Kyotani S; Waki M; Nishioeda Y; Harano Y; Omae T
    Am J Hypertens; 1994 Oct; 7(10 Pt 2):154S-160S. PubMed ID: 7826566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular events during antihypertensive treatment.
    Madren EM
    J Fam Pract; 1996 Dec; 43(6):534. PubMed ID: 8969693
    [No Abstract]   [Full Text] [Related]  

  • 20. Isradipine (Lomir) in the treatment of hypertension. Introduction.
    Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):1. PubMed ID: 2143456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.